Agio Pharmaceuticals Limited Dexamethasone Export Data — India (DGFT 2022–2026)

Name: Agio Pharmaceuticals Limited Dexamethasone Export Records India — #13 Exporter, 84 Shipments, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dexamethasone

India Pharmaceutical Trade Intelligence

$181.4M808 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES62.7%India → ETHIOPIA8.0%

ImportsBRAZIL → India$30.7B CHINA → India$42.9M

#1 Buyer: DR REDDYS

Agio Pharmaceuticals Limited — Dexamethasone Exporter #13 | $1.9M Trade Value | TransData Nexus | TransData Nexus

Agio Pharmaceuticals Limited — Dexamethasone Exporter Profile

Indian Pharmaceutical Exporter · #13 for Dexamethasone · $1.9M export value · DGFT Verified

Agio Pharmaceuticals Limited is the #13 Indian exporter of Dexamethasone with $1.9M in export value and 84 verified shipments. Agio Pharmaceuticals Limited holds a 1.1% market share in Dexamethasone exports across 7 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.

Agio Pharmaceuticals Limited — Dexamethasone Export Profile: Buyers & Destinations

Agio Pharmaceuticals Limited Dexamethasone export treemap — buyers and destination countries | TransData Nexus

Where Does Agio Pharmaceuticals Limited Export Dexamethasone?

Country	Value	Shipments	Share
UZBEKISTAN	$789.9K	31	44.6%
KAZAKISTAN	$410.3K	19	23.2%
KAZAKHSTAN	$241.8K	9	13.7%
MOLDOVA,REPUBLIC OF	$111.6K	10	6.3%

Who Are the Top Buyers of Dexamethasone from Agio Pharmaceuticals Limited?

Buyer	Country	Value	Orders
AGIO HEALTHCARE INTERNATIONAL LLC	UZBEKISTAN	$496.4K	23
LLP AGIO PHARMACEUTICALS LIMITED	KAZAKISTAN	$358.6K	11
AMRITA PHARMA LLC	UZBEKISTAN	$258.3K	7
LLC AK NEIT	KAZAKISTAN	$239.7K	10
ESCULAP FARM	MOLDOVA,REPUBLIC OF	$147.8K	13
AVERSI PHARMA LLC	GEORGIA	$80.5K	6
OSOO ELYAI	KYRGHYSTAN	$62.9K	4
AMRITA PHARMA LLC,	UZBEKISTAN	$35.3K	1
SAGLYK E S	TURKMENISTAN	$27.0K	1
LLC AK NEIT REPUBLIC OF KAZAKHSTAN CITY SHYMKENT TURAN	KAZAKHSTAN	$25.7K	1

Agio Pharmaceuticals Limited supplies Dexamethasone to 15 buyers globally. The largest buyer is AGIO HEALTHCARE INTERNATIONAL LLC (UZBEKISTAN), followed by LLP AGIO PHARMACEUTICALS LIMITED (KAZAKISTAN) and AMRITA PHARMA LLC (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dexamethasone Formulations Does Agio Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP)	$657.9K	22
DEXAMETHASONE - AGIO SOLUTION FOR INJECT	$330.4K	20
DEXAMETHASONE AGIO SOLUTION FOR INJECTIO	$135.0K	3
DEXAMETHASONE - AGIO SOLUTION FORINJECTION 4MG/ML (DEXAMETHASONE SODIUMPHOSPHATE INJECTION BP)NOS	$85.0K	6
DDEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP)NOS	$58.3K	3
DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML	$50.0K	1
DEXAMETHASONE-AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATEINJECTION BP)	$47.2K	1
DEXAMETHASONE-AGIO SOLUTION FOR INJ.4MG/MLDEXAMETHASONE SODIUM PHOSPHATE INJ. BPBNO.I23061 TO I23065 MD.10/23 ED.09/25	$40.6K	1
DEXAMETHASONE - AGIO SOLUTION FOR INJ.	$37.9K	2
DEXAMETHASONE INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP)NOS	$35.4K	2

Agio Pharmaceuticals Limited exports 29 distinct Dexamethasone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETH with 22 shipments worth $657.9K.

How Does Agio Pharmaceuticals Limited Compare to Nearest Dexamethasone Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DR.REDDY'S LABORATORIES LTD	$2.3M	46	1	$50.0K
10	SOMERSET THERAPEUTICS LIMITED	$2.2M	44	1	$50.0K
13	AGIO PHARMACEUTICALS LIMITED ★	$1.9M	84	7	$22.8K
14	SOMERSET THERAPEUTICS PRIVATE LIMITED	$1.3M	25	1	$50.0K
2	DR REDDYS LABORATORIES LIMITED	$1.1M	22	1	$50.0K

Agio Pharmaceuticals Limited ranks #13 among 808 Indian Dexamethasone exporters. Average shipment value of $22.8K compared to the market average of $39.8K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and SOMERSET THERAPEUTICS LIMITED.

Which Indian Ports Ship Dexamethasone Exports?

Port	Shipments	% Share
SAHAR AIR	1,214	13.8%
SAHAR AIR CARGO ACC (INBOM4)	1,121	12.8%
NHAVA SHEVA SEA (INNSA1)	748	8.5%
DELHI AIR CARGO ACC (INDEL4)	509	5.8%
DELHI AIR	476	5.4%
JNPT/ NHAVA SHEVA SEA	472	5.4%
Bombay Air	327	3.7%
JNPT	320	3.6%

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Dexamethasone Exports

Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.

In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.

The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.

Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 84 individual customs records matching Agio Pharmaceuticals Limited exporting Dexamethasone, covering 29 formulations to 8 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 176+ countries, 2,257+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dexamethasone

Dexamethasone

Agio Pharmaceuticals Limited — Dexamethasone Exporter Profile

Agio Pharmaceuticals Limited — Dexamethasone Export Profile: Buyers & Destinations

Where Does Agio Pharmaceuticals Limited Export Dexamethasone?

Who Are the Top Buyers of Dexamethasone from Agio Pharmaceuticals Limited?

What Is India's Total Dexamethasone Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Dexamethasone Exports?

How Does Agio Pharmaceuticals Limited Compare to Other Indian Dexamethasone Exporters?

What Dexamethasone Formulations Does Agio Pharmaceuticals Limited Export?

How Does Agio Pharmaceuticals Limited Compare to Nearest Dexamethasone Exporters?

Which Indian Ports Ship Dexamethasone Exports?

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Dexamethasone Exports

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Agio Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dexamethasone Export Data from Agio Pharmaceuticals Limited

Dexamethasone Stats

Company Overview

Top Products by Agio Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source